<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-NTF-2799</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-2799</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КРАТКИЕ СООБЩЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SHORT COMMUNICATIONS</subject></subj-group></article-categories><title-group><article-title>Активность ядерного фактора транскрипции kB (NF-kB) в популяциях лимфоцитов у детей с болезнью Вильсона-Коновалова</article-title><trans-title-group xml:lang="en"><trans-title>Nuclear transcription factor kB (NF-kB) activity in lymphocyte populations in children with Wilson-Konovalov disease</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9213-5281</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Курбатова</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kurbatova</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Курбатова Ольга Владимировна — кандидат медицинских наук, старший научный сотрудник лаборатории экспериментальной иммунологии и вирусологии.</p><p>119991, Москва, Ломоносовский пр. 2, стр. 1</p><p>Тел.: 8 (499) 134-13-98. Факс: 8 (499) 134-70-01</p></bio><bio xml:lang="en"><p>Olga V. Kurbatova - PhD (Medicine), Senior Research Associate, Laboratory of Experimental Immunology and Virology, National Medical Research Center of Children's Health.</p><p>2 Lomonosovsky Ave, Bldg 1 Moscow 119991</p><p>Phone: +7 (499) 134-13-98. Fax: +7 (499) 134-70-01</p></bio><email xlink:type="simple">putintseva@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0896-6996</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петричук</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Petrichuk</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Петричук Светлана Валентиновна  — доктор биологических наук, профессор, главный научный сотрудник лаборатории экспериментальной иммунологии и вирусологии.</p><p>Москва</p></bio><bio xml:lang="en"><p>PhD, MD (Biology), Professor, Chief Research Associate, Laboratory of Experimental Immunology and Virology, National Medical Research Center of Children's Health.</p><p>Moscow</p></bio><email xlink:type="simple">cito@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7771-3314</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Купцова</surname><given-names>Д. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuptsova</surname><given-names>D. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Купцова Дарья Геннадьевна — младший научный сотрудник, врач клинической лабораторной диагностики лаборатории экспериментальной иммунологии и вирусологии.</p><p>Москва</p></bio><bio xml:lang="en"><p>Junior Research Associate, Clinical Laboratory Physician, Laboratory of Experimental Immunology and Virology, National Medical Research Center of Children's Health.</p><p>Moscow</p></bio><email xlink:type="simple">dg.kuptsova@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2881-4703</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мовсисян</surname><given-names>Г. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Movsisyan</surname><given-names>G. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мовсисян Гоар Борисовна — кандидат медицинских наук, старший научный сотрудник лаборатории редких наследственных болезней, врач- гастроэнтеролог гастроэнтерологического отделения с гепатологической группой.</p><p>Москва</p></bio><bio xml:lang="en"><p>PhD (Medicine), Senior Research Associate, Laboratory of Rare Hereditary Diseases, Gastroenterologist of the Gastroenterology Department with the Hepatological Group, National Medical Research Center of Children's Health.</p><p>Moscow</p></bio><email xlink:type="simple">movsisyan@nczd.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4704-6885</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Радыгина</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Radygina</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Радыгина Татьяна Вячеславовна — кандидат медицинских наук, старший научный сотрудник лаборатории экспериментальной иммунологии и вирусологии.</p><p>Москва</p></bio><bio xml:lang="en"><p>PhD (Medicine), Senior Research Associate, Laboratory of Experimental Immunology and Virology, National Medical Research Center of Children's Health.</p><p>Moscow</p></bio><email xlink:type="simple">tvradigina@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9064-6443</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Комарова  </surname><given-names>А. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Komarova</surname><given-names>A. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Комарова Алина Дмитриевна — врач-педиатр гастроэнтерологического отделения с гепатологической группой.</p><p>Москва</p></bio><bio xml:lang="en"><p>Paediatrician, Gastroenterology Department with the Hepatological Group, National Medical Research Center of Children's Health.</p><p>Moscow</p></bio><email xlink:type="simple">komarova.alina.d@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1549-2728</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Анушенко</surname><given-names>А. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Anushenko</surname><given-names>A. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Анушенко Антон Олегович — врач-гастроэнтеролог гастроэнтерологического отделения с гепатологической группой.</p><p>Москва</p></bio><bio xml:lang="en"><p>Gastroenterologist of the Gastroenterology Department with the Hepatological Group, National Medical Research Center of Children's Health.</p><p>Moscow</p></bio><email xlink:type="simple">anoushenko@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5645-5181</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фрейдлин</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Freidlin</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лаборант-исследователь лаборатории экспериментальной иммунологии и вирусологии.</p><p>Москва</p></bio><bio xml:lang="en"><p>Laboratory Assistant, Laboratory of Experimental Immunology and Virology, National Medical Research Center of Children's Health.</p><p>Moscow</p></bio><email xlink:type="simple">frdl-cito@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8923-4652</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Семикина</surname><given-names>Е. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Semikina</surname><given-names>E. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор медицинских наук, руководитель лабораторного отдела ФГАУ «НМИЦ здоровья детей» МЗ РФ; профессор кафедры педиатрии и детской ревматологии ФГАОУ ВО «ПМГМУ им. И.М. Сеченова» МЗ РФ (Сеченовский университет).</p><p>Москва</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Head, Laboratory Department, National Medical Research Center of Children's Health; Professor, Department of Pediatrics and Pediatric Rheumatology, I. Sechenov First Moscow State Medical University (Sechenov University).</p><p>Moscow</p></bio><email xlink:type="simple">semikina@nczd.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4905-2373</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Потапов</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Potapov</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Потапов Александр Сергеевич — доктор медицинских наук, профессор, главный научный сотрудник лаборатории научных основ детской гастроэнтерологии и гепатологии, заведующий гастроэнтерологическим отделением с гепатологической группой ФГАУ «НМИЦ здоровья детей» МЗ РФ; профессор кафедры педиатрии и детской ревматологии ФГАОУ ВО «ПМГМУ им. И.М. Сеченова» МЗ РФ (Сеченовский университет).</p><p>Москва</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Chief Research Associate, Laboratory of Scientific Foundations of Pediatric Gastroenterology and Hepatology, Head of Gastroenterology Department with Hepatology Group, National Medical Research Center of Children's Health; Professor, Department of Pediatrics and Pediatric Rheumatology, I. Sechenov First Moscow State Medical University (Sechenov University).</p><p>Moscow</p></bio><email xlink:type="simple">potapov@nczd.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8586-7946</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фисенко</surname><given-names>А. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Fisenko</surname><given-names>A. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Фисенко Андрей Петрович — доктор медицинских наук, профессор, директор ФГАУ «НМИЦ здоровья детей» МЗ РФ.</p><p>Москва</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Director, National Medical Research Center of Children's Health.</p><p>Moscow</p></bio><email xlink:type="simple">fisenko@nczd.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАУ «Национальный медицинский исследовательский центр здоровья детей» Министерства здравоохранения РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center of Children's Health</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГАУ «Национальный медицинский исследовательский центр здоровья детей» Министерства здравоохранения РФ; ФГАОУ ВО «Первый Московский государственный медицинский университет имени И.М. Сеченова» Министерства здравоохранения РФ (Сеченовский университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center of Children's Health; I. Sechenov First Moscow State Medical University (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>01</day><month>06</month><year>2023</year></pub-date><volume>25</volume><issue>5</issue><fpage>1205</fpage><lpage>1212</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Курбатова О.В., Петричук С.В., Купцова Д.Г., Мовсисян Г.Б., Радыгина Т.В., Комарова   А.Д., Анушенко А.О., Фрейдлин Е.В., Семикина Е.Л., Потапов А.С., Фисенко А.П., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Курбатова О.В., Петричук С.В., Купцова Д.Г., Мовсисян Г.Б., Радыгина Т.В., Комарова   А.Д., Анушенко А.О., Фрейдлин Е.В., Семикина Е.Л., Потапов А.С., Фисенко А.П.</copyright-holder><copyright-holder xml:lang="en">Kurbatova O.V., Petrichuk S.V., Kuptsova D.G., Movsisyan G.B., Radygina T.V., Komarova A.D., Anushenko A.O., Freidlin E.V., Semikina E.L., Potapov A.S., Fisenko A.P.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/2799">https://www.mimmun.ru/mimmun/article/view/2799</self-uri><abstract><p>Болезнь Вильсона (БВ) — редкое наследственное заболевание, вызванное дефицитом транспортера АТФ7В. Накопление меди может вызывать повреждение органов и клеток, преимущественно печени. Воздействие меди может модулировать синтез цитокинов посредством молекулярных и клеточных сигнальных путей, включая путь ядерного фактора транскрипции NF-kB. NF-kB является главным регулятором воспаления и гибели клеток, действует как центральное звено между повреждением печени, фиброзом и гепатоцеллюлярной карциномы. Избыток NF-kB-зависимого цитокинового ответа стимулирует воспалительные реакции, но и чрезмерное ингибирование NF-kB может негативно влиять на жизнеспособность гепатоцитов. Метод проточной цитометрии с визуализацией — Amnis ImageStreamX позволяет оценить активность NF-kB (% активированных клеток, в популяциях клеток). Цель работы — оценить активность NF-kB в популяциях лимфоцитов у детей с болезнью Вильсона-Коновалова. Иммунофенотипирование лимфоцитов и оценку уровня транслокации NF-kB проводили у 52 ребенка с БВ и у 25 детей группы сравнения. Массовую концентрацию меди в суточной моче определяли атомно-абсорбционным методом с помощью спектрометра AAnalyst 800. У детей с БВ содержание клеток с транслокацией NF-kB варьировало от 5 до 90% в зависимости от популяции лимфоцитов, наибольший уровень выявлен в В-клетках и составил 57,5 (37-68) %. Показана достоверная разница в распределениях количества клеток с транслокацией NF-kB в популяциях лимфоцитов между БВ и здоровыми детьми (F-критерий, р &lt; 0,01). Для детей с БВ в большинстве случаях характерно снижение активности фактора транскрипции NF-kB в популяциях В-клеток (в 43% случаев), Т-хелперов (48%), Т-цитотоксических (44%) и Тh17-лимфоцитов (41%). У детей с БВ концентрация меди варьировала от 9,7 до 2582 мкг/сут, Med = 616 (210-1173). Получена прямая зависимость между содержанием меди в моче и уровнем транслокации NF-kB в В-лимфоцитах, r = 0,34, р = 0,016. Активность фактора NF-kB коррелирует с биохимическими маркерами тяжести поражения печени (АЛТ, АСТ, ГГТ) и с содержанием меди в моче. Исследование сигнального пути NF-kB представляется перспективным для большего понимания патогенетических механизмов формирования процессов воспаления и фиброза печени у детей с БВ.</p></abstract><trans-abstract xml:lang="en"><p>Wilson's disease (WD) is a rare hereditary disease caused by a deficiency of the ATF7B transporter. The accumulation of copper can cause damage to organs and cells, mainly the liver. Copper exposure can modulate cytokine synthesis through molecular and cellular signaling pathways, including the nuclear transcription factor NF-kB pathway. NF-kB is the main regulator of inflammation and cell death, acts as a central link between liver damage, fibrosis and hepatocellular carcinoma. An excess of NF-kB-dependent cytokine response stimulates inflammatory reactions, but excessive inhibition of NF-kB can negatively affect the viability of hepatocytes. Method of flow cytometry with visualization — Amnis ImageStreamX allows to evaluate the activity of NF-kB (% of activated cells in cell populations). The aim: to evaluate the activity of NF-kB in lymphocyte populations in children with WD disease. Immunophenotyping of lymphocytes and assessment of the level of translocation of NF-kB were performed in 52 children with WD and in 25 children of comparison group. The mass concentration of copper in daily urine was determined by atomic absorption method using the AAnalyst 800 spectrometer. In children with WD, the content of cells with NF-kB translocation varied from 5 to 90% depending on the lymphocyte population; the highest level was detected in B cells — 57.5 (37-68) %. A significant difference in distributions of the number of cells with NF-kB translocation between WD and healthy children was shown (F-criterion, p &lt; 0.01). In most cases, children with WD are characterized by a decrease in the activity of NF-kB in populations of B cells (in 43% of cases), T helper cells (48%), T cytotoxic (44%) and Th17 lymphocytes (41%). In children with WD, the concentration of copper varied from 9.7 to 2582 mcg/day, Me = 616 (210-1173). A direct relationship was obtained between the copper content in urine and the level of translocation of NF-kB in B lymphocytes, r = 0.34, p = 0.016. The activity of the NF-kB correlates with biochemical markers of the severity of liver damage (ALT, AST, GGT) and with copper content in urine. The study of the NF-kB signaling pathway seems promising for a better understanding of the pathogenetic mechanisms of the formation of inflammation and liver fibrosis in children with WD.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>болезнь Вильсона-Коновалова</kwd><kwd>лимфоциты</kwd><kwd>Th17</kwd><kwd>Tc17</kwd><kwd>проточная цитометрия с визуализацией</kwd><kwd>NF-kB</kwd></kwd-group><kwd-group xml:lang="en"><kwd>children</kwd><kwd>Wilson-Konovalov disease</kwd><kwd>lymphocytes</kwd><kwd>Th17</kwd><kwd>Tc17</kwd><kwd>flow cytometry with visualization</kwd><kwd>NF-kB</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Barteneva N.S., Vorobjev I.A. Imaging Flow Cytometry Methods and protocols. Methods Mol. Biol., 2017, pp. 178-188.</mixed-citation><mixed-citation xml:lang="en">Barteneva N.S., Vorobjev I.A. Imaging Flow Cytometry Methods and protocols. Methods Mol. Biol., 2017, pp. 178-188.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Deng H., Zhu S., Yang H., Cui H., Guo H., Deng J., Ren Z., Geng Y., Ouyang P., Xu Z., Deng Y., Zhu Y. Dysregulation of inflammatory pathways triggered by copper exposure. Biol. Trace Elem. Res., 2023, Vol. 201, no. 2, pp. 539-548.</mixed-citation><mixed-citation xml:lang="en">Deng H., Zhu S., Yang H., Cui H., Guo H., Deng J., Ren Z., Geng Y., Ouyang P., Xu Z., Deng Y., Zhu Y. Dysregulation of inflammatory pathways triggered by copper exposure. Biol. Trace Elem. Res., 2023, Vol. 201, no. 2, pp. 539-548.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Fisenko A.P., Surkov N.N., Potapov A.S. Wilson's disease in children. Moscow: National Medical Research Center of Children's Health, 2019. Р. 83. (In Russ.)</mixed-citation><mixed-citation xml:lang="en">Fisenko A.P., Surkov N.N., Potapov A.S. Wilson's disease in children. Moscow: National Medical Research Center of Children's Health, 2019. Р. 83. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kuptsova D.G., Petrichuk S.V., Murashkin N.N., Kurbatova O.V., Radygina T.V., Khotko A.A., Ivanov R.A. Activity of nuclear factor kB in lymphocyte populations of children with psoriasis. Bulletin of the Russian State Medical University, 2022, no. 2, pp. 28-35. (In Russ.)</mixed-citation><mixed-citation xml:lang="en">Kuptsova D.G., Petrichuk S.V., Murashkin N.N., Kurbatova O.V., Radygina T.V., Khotko A.A., Ivanov R.A. Activity of nuclear factor kB in lymphocyte populations of children with psoriasis. Bulletin of the Russian State Medical University, 2022, no. 2, pp. 28-35. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kurbatova O.V., Kuptsova D.G., Bezrukavnikova L.M., Radygina T.V., Movsisyan G.B., Anushenko A.O., Komarova A.D., Potapov A.S., Petrichuk S.V, Fisenko A.P. Features of immune status in children with Wilson-Konovalov disease at different stages of liver fibrosis. Russian Journal of Immunology, 2022, Vol. 25, no. 4, pp. 453-460. (In Russ.)</mixed-citation><mixed-citation xml:lang="en">Kurbatova O.V., Kuptsova D.G., Bezrukavnikova L.M., Radygina T.V., Movsisyan G.B., Anushenko A.O., Komarova A.D., Potapov A.S., Petrichuk S.V, Fisenko A.P. Features of immune status in children with Wilson-Konovalov disease at different stages of liver fibrosis. Russian Journal of Immunology, 2022, Vol. 25, no. 4, pp. 453-460. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Lucena-Valera A., Ruz-Zafra P., Ampuero J. Wilson's disease: overview. Enfermedad de Wilson. Med. Clin. (Barc.), 2023, Vol. 160, no. 6, pp. 261-267.</mixed-citation><mixed-citation xml:lang="en">Lucena-Valera A., Ruz-Zafra P., Ampuero J. Wilson's disease: overview. Enfermedad de Wilson. Med. Clin. (Barc.), 2023, Vol. 160, no. 6, pp. 261-267.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Luedde T., Schwabe R.F. NF-KB in the liver-linking injury, fibrosis and hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol., 2011, Vol. 8, no. 2, pp. 108-118.</mixed-citation><mixed-citation xml:lang="en">Luedde T., Schwabe R.F. NF-KB in the liver-linking injury, fibrosis and hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol., 2011, Vol. 8, no. 2, pp. 108-118.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Mehto S., Kundu S., Chauhan S., Chauhan S. RIPosomes are targets of IRGM-SQSTM1-dependent autophagy. Autophagy, 2023, Vol. 19, no. 3, pp. 1045-1047.</mixed-citation><mixed-citation xml:lang="en">Mehto S., Kundu S., Chauhan S., Chauhan S. RIPosomes are targets of IRGM-SQSTM1-dependent autophagy. Autophagy, 2023, Vol. 19, no. 3, pp. 1045-1047.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Oakley F., Mann J., Nailard S., Smart D., Mungalsingh N., Constandinou C., Ali S., Wilson S.J., Millward- Sadler H., Iredale J.P., Mann D.A. Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury. Am. J. Pathol., 2005, Vol. 166, no. 3, pp. 695-708.</mixed-citation><mixed-citation xml:lang="en">Oakley F., Mann J., Nailard S., Smart D., Mungalsingh N., Constandinou C., Ali S., Wilson S.J., Millward- Sadler H., Iredale J.P., Mann D.A. Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury. Am. J. Pathol., 2005, Vol. 166, no. 3, pp. 695-708.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Petrichuk S.V., Radygina T.V., Kuptsova D.G., Kurbatova O.V., Semikina E.L., Murashkin N.N., Potapov A.S., Fisenko A.P. Evaluation of anti-TNF treatment efficiency in children with immune-dependent diseases by means of testing the NF-kB activity in lymphocyte populations. Russian Journal of Immunology, 2022, Vol. 25, no. 4, pp. 491-498. (In Russ.)</mixed-citation><mixed-citation xml:lang="en">Petrichuk S.V., Radygina T.V., Kuptsova D.G., Kurbatova O.V., Semikina E.L., Murashkin N.N., Potapov A.S., Fisenko A.P. Evaluation of anti-TNF treatment efficiency in children with immune-dependent diseases by means of testing the NF-kB activity in lymphocyte populations. Russian Journal of Immunology, 2022, Vol. 25, no. 4, pp. 491-498. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Petrichuk S., Radigina T., Gerasimova D., Illarionov A., Anushenko A., Erlikh-Fox T., Potapov A., P070 The level of nuclear factor kappa B (NF-kB) translocation during infliximab therapy in children with IBD. J. Crohns Colitis, 2019, Vol.13, Iss. suppl. 1, pp. S120-S121.</mixed-citation><mixed-citation xml:lang="en">Petrichuk S., Radigina T., Gerasimova D., Illarionov A., Anushenko A., Erlikh-Fox T., Potapov A., P070 The level of nuclear factor kappa B (NF-kB) translocation during infliximab therapy in children with IBD. J. Crohns Colitis, 2019, Vol.13, Iss. suppl. 1, pp. S120-S121.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Przybylkowski A., Szeligowska J., Januszewicz M., Raszeja-Wyszomirska J., Szczepankiewicz B., Nehring P, Gornicka B., Litwin T., Czlonkowska A. Evaluation of liver fibrosis in patients with Wilson's disease. Eur. J. Gastroenterol. Hepatol., 2021, Vol. 33, no. 4, pp. 535-540.</mixed-citation><mixed-citation xml:lang="en">Przybylkowski A., Szeligowska J., Januszewicz M., Raszeja-Wyszomirska J., Szczepankiewicz B., Nehring P, Gornicka B., Litwin T., Czlonkowska A. Evaluation of liver fibrosis in patients with Wilson's disease. Eur. J. Gastroenterol. Hepatol., 2021, Vol. 33, no. 4, pp. 535-540.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang T., Hu J., Wang X., Zhao X., Li Z., Niu J., Steer C.J Zheng G., Song G. MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-KB-TNFa pathway. J Hepatol., 2019, Vol. 70, no. 1, pp. 87-96.</mixed-citation><mixed-citation xml:lang="en">Zhang T., Hu J., Wang X., Zhao X., Li Z., Niu J., Steer C.J Zheng G., Song G. MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-KB-TNFa pathway. J Hepatol., 2019, Vol. 70, no. 1, pp. 87-96.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
